Skip to main content

Cisatracurium Besylate Injection

Last Updated: August 11, 2022
Status: Current

Products Affected - Description
    • Cisatracurium besylate injection, AuroMedics, 2 mg/mL, 10 mL vial, 10 count, NDC 55150-0286-10
Reason for the Shortage
    • AuroMedics has cisatracurium on shortage due to increased demand.
    • Fresenius Kabi has cisatracurium injection available
    • Meitheal Pharmaceuticals has cisatracurium available.
    • Pfizer has cisatracurium injection available
    • Sandoz has cisatracurium injection available
    • Somerset has cisatracurium injection available.
    • Teva has cisatracurium injection available
    • AbbVie has Nimbex available.
Available Products
    • Nimbex injection, AbbVie, 10 mg/mL, 20 mL vial, 10 count, NDC 00074-4382-20
    • Nimbex injection, AbbVie, 2 mg/mL, 10 mL vial, 10 count, NDC 00074-4380-10
    • Nimbex injection, AbbVie, 2 mg/mL, 5 mL vial, 10 count, NDC 00074-4378-05
    • Cisatracurium besylate injection, AuroMedics, 2 mg/mL, 5 mL vial, 10 count, NDC 55150-0284-10
    • Cisatracurium besylate injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 10 count, NDC 63323-0418-20
    • Cisatracurium besylate injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 10 count, NDC 63323-0417-10
    • Cisatracurium besylate injection, Fresenius Kabi, 2 mg/mL, 5 mL vial, 10 count, NDC 63323-0416-05
    • Cisatracurium besylate injection, Meitheal Pharmaceuticals, 10 mg/mL, 20 mL vial, 10 count, NDC 71288-0713-21
    • Cisatracurium besylate injection, Meitheal Pharmaceuticals, 2 mg/mL, 10 mL vial, 10 count, NDC 71288-0714-11
    • Cisatracurium besylate injection, Meitheal Pharmaceuticals, 2 mg/mL, 5 mL vial, 10 count, NDC 71288-0712-06
    • Cisatracurium besylate injection, Pfizer, 10 mg/mL, 20 mL vial, 10 count, NDC 00409-1103-01
    • Cisatracurium besylate injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-1208-01
    • Cisatracurium besylate injection, Pfizer, 2 mg/mL, 5 mL vial, 10 count, NDC 00409-1098-02
    • Cisatracurium besylate injection, Sandoz, 10 mg/mL, 20 mL vial, 10 count, NDC 00781-3153-95
    • Cisatracurium besylate injection, Sandoz, 2 mg/mL, 10 mL vial, 10 count, NDC 00781-3152-95
    • Cisatracurium besylate injection, Sandoz, 2 mg/mL, 5 mL vial, 10 count, NDC 00781-3150-95
    • Cisatracurium besylate injection, Somerset Therapeutics LLC, 10 mg/mL, 20 mL vial, 10 count, NDC 70069-0151-10
    • Cisatracurium besylate injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 10 count, NDC 70069-0161-10
    • Cisatracurium besylate injection, Somerset Therapeutics LLC, 2 mg/mL, 5 mL vial, 10 count, NDC 70069-0141-10
    • Cisatracurium besylate injection, Teva, 10 mg/mL, 20 mL vial, 10 count, NDC 00703-2056-03
    • Cisatracurium besylate injection, Teva, 2 mg/mL, 10 mL vial, 10 count, NDC 00703-2045-03
    • Cisatracurium besylate injection, Teva, 2 mg/mL, 5 mL vial, 10 count, NDC 00703-2033-03

Estimated Resupply Dates

    • Most marketed presentations are available.

Updated

Updated August 11, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 3, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.